Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Morphinan-6-one derivatives are investigated for their analgesic properties.
• Understanding structure-activity relationships is crucial for developing new pain therapeutics.

Purpose of the Study:

• To synthesize novel 8-alkyl-3-methoxy-17-methylmorphinan-6-ones and isomorphinan-6-ones.
• To evaluate the analgesic and narcotic agonist-antagonist activities of these compounds.
• To explore the influence of the 8-substituent on pharmacological activity.

Main Methods:

• Synthesis of morphinan-6-one and isomorphinan-6-one scaffolds via conjugate addition of organocuprates.
• Modification of the 17-position with cycloalkylmethyl groups to generate mixed narcotic agonists-antagonists.
• Pharmacological evaluation in animal models, including dependence studies in rats and activity assessment in morphine-dependent monkeys.

Main Results:

• A series of potent analgesic 17-methylmorphinan-6-one and isomorphinan-6-one derivatives were synthesized.
• Conversion to mixed narcotic agonists-antagonists was achieved by altering the 17-substituent.
• The 8-alkyl substituent modulated the observed pharmacological profile.
• Compound 10Ca (17-(cyclobutylmethyl)-3-hydroxy-8 beta-methylmorphinan-6-one) exhibited a low agonist-antagonist ratio (0.1).
• Compound 10Ca did not induce or support physical dependence in rats.
• In morphine-dependent monkeys, 10Ca behaved as a typical narcotic agent.

Conclusions:

• Novel morphinan-6-one derivatives possess significant analgesic and mixed agonist-antagonist properties.
• The 8-substituent plays a key role in determining the pharmacological profile, including agonist-antagonist activity and dependence potential.
• Compound 10Ca represents a promising candidate with potential therapeutic applications due to its unique pharmacological characteristics.